Save Entresto for Persistent Heart Failure Symptoms
You'll hear lots of buzz about Entresto (en-TRESS-toh), a new drug for systolic heart failure.
It's the first "angiotensin receptor neprilysin inhibitor" (ARNI)...and combines valsartan with sacubitril (sah-KYOO-bih-tril).
Sacubitril works by inhibiting the enzyme neprilysin. This increases sodium loss and vasodilation...and enhances ARB efficacy.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: MD includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote